moksifloksacin lek 400 mg filmsko obložene tablete
lek d.d. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
moloxin 400 mg/250 ml raztopina za infundiranje
krka, d.d., novo mesto - moksifloksacin - raztopina za infundiranje - moksifloksacin 1,6 mg / 1 ml - moksifloksacin
kimoks 400 mg filmsko obložene tablete
alkaloid - int d.o.o. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
prevymis
merck sharp & dohme b.v. - letermovir - okužbe s citomegalovirusom - antivirusi za sistemsko uporabo - prevymis je indicirano za profilakso reaktivacije citomegalovirusom (cmv) in bolezni pri odraslih serološko cmv prejemniki [r +] alogenskih krvotvornih matičnih celic presaditev (hsct). upoštevati je treba uradne smernice za ustrezno uporabo protivirusnih agenti.
prevymis 240 mg koncentrat za raztopino za infundiranje
merck sharp & dohme ltd - letermovir - koncentrat za raztopino za infundiranje - letermovir 240 mg / 12 ml
prevymis 240 mg filmsko obložene tablete
merck sharp & dohme ltd - letermovir - filmsko obložena tableta - letermovir 240 mg / 1 tableta
prevymis 480 mg filmsko obložene tablete
merck sharp & dohme ltd - letermovir - filmsko obložena tableta - letermovir 480 mg / 1 tableta
prevymis 480 mg koncentrat za raztopino za infundiranje
merck sharp & dohme ltd - letermovir - koncentrat za raztopino za infundiranje - letermovir 480 mg / 24 ml
virbagen omega
virbac s.a. - rekombinantni omega interferon mačjega izvora - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. pri mačkah, okuženih s fiv, je bila smrtnost nizka (5%) in na zdravljenje ni vplivala.